The expression of PLK1, a key regulator of cell cycle progression and a marker of cellular proliferation [18,19,20,21,22,23], was inversely correlated with the vector-prone increase in DAPK1 re-expression (Figure 3C), supporting an anti-proliferative role of DAPK1 in ovarian cancer. Here, PLK1 is linked to ovarian carcinoma.